论文部分内容阅读
1临床资料患者,男,73岁,体重85 kg,身高178 cm,胃癌晚期,于2009年11月8日开始给予卡培他滨片(希罗达,上海罗氏制药有限公司生产,批号SH0102,规格:0.5 g),2.0 g,po,bid。用药2～3 d后,患者出现呕吐、腹泻(一天4次左右)、乏力,同时伴有烦躁、发脾气,不能控制自己的情绪。给予整肠生胶囊、奥美拉唑片对症治疗,腹泻、呕吐症状有所缓解,勉强完成第一个疗程(14 d);停药1～2 d后,患者腹泻、呕吐症状消失,烦躁、发脾气现象逐渐减轻。停药休息7 d后,进入第二个疗程,用药2～3 d后,患者又出现上述症状,因
1 clinical data, male, 73 years old, weight 85 kg, height 178 cm, advanced gastric cancer, on November 8, 2009 began capecitabine tablets (Xeloda, Shanghai Roche Pharmaceutical Co., Ltd., batch number SH0102, Specification: 0.5 g), 2.0 g, po, bid. 2 to 3 days after treatment, the patient developed vomiting, diarrhea (about 4 times a day), fatigue, accompanied by irritability, temper, can not control their emotions. The patients were given diarrhea and vomiting disappeared and irritable after a period of 1 to 2 days. The patients were treated with omeprazole tablets for symptomatic treatment, diarrhea and vomiting. Lending temper gradually reduced. After taking a rest 7 days, enter the second course of treatment, medication 2 ~ 3 d, the patient again the above symptoms,